SE9603461D0 - New compounds - Google Patents

New compounds

Info

Publication number
SE9603461D0
SE9603461D0 SE9603461A SE9603461A SE9603461D0 SE 9603461 D0 SE9603461 D0 SE 9603461D0 SE 9603461 A SE9603461 A SE 9603461A SE 9603461 A SE9603461 A SE 9603461A SE 9603461 D0 SE9603461 D0 SE 9603461D0
Authority
SE
Sweden
Prior art keywords
formula
variable
amino acid
description
meaning defined
Prior art date
Application number
SE9603461A
Other languages
Swedish (sv)
Inventor
Haakan Bergstrand
Tomas Eriksson
Magnus Lindvall
Bengt Saernstrand
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9603461A priority Critical patent/SE9603461D0/en
Publication of SE9603461D0 publication Critical patent/SE9603461D0/en
Priority to PCT/SE1997/001548 priority patent/WO1998012214A1/en
Priority to AU44059/97A priority patent/AU4405997A/en

Links

Abstract

Physiologically active peptides of formula (I) A-R1-R2-R3-(R4)x-B wherein each variable has the meaning defined in the description, at least one of R1, R2 and R3 being R8 and at most one of R1, R2 and R3 being cysteine; and R8 is an amino acid residue of formula (II) or formula (III), wherein each variable has the meaning defined in the description, the entire peptide sequence containing 3 to 30 amino acid residues. These peptides are absorbable by the epithelial cell lining in a mammal resulting in a modulated immune response and thereby a therapeutic effect against disease.
SE9603461A 1996-09-23 1996-09-23 New compounds SE9603461D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE9603461A SE9603461D0 (en) 1996-09-23 1996-09-23 New compounds
PCT/SE1997/001548 WO1998012214A1 (en) 1996-09-23 1997-09-15 Cysteine analogue containing peptides having immunomodulatory effect
AU44059/97A AU4405997A (en) 1996-09-23 1997-09-15 Cysteine analogue containing peptides having immunomodulatory effect

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9603461A SE9603461D0 (en) 1996-09-23 1996-09-23 New compounds

Publications (1)

Publication Number Publication Date
SE9603461D0 true SE9603461D0 (en) 1996-09-23

Family

ID=20403983

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9603461A SE9603461D0 (en) 1996-09-23 1996-09-23 New compounds

Country Status (3)

Country Link
AU (1) AU4405997A (en)
SE (1) SE9603461D0 (en)
WO (1) WO1998012214A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10973920B2 (en) 2014-06-30 2021-04-13 Glykos Finland Oy Saccharide derivative of a toxic payload and antibody conjugates thereof
EP3464336B1 (en) 2016-06-01 2022-03-16 Athira Pharma, Inc. Compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1366088A (en) * 1987-01-28 1988-08-24 Ortho Pharmaceutical Corporation Immunosuppressive peptides and methods of use
DE3841759A1 (en) * 1988-12-12 1990-06-13 Basf Ag NEW TNF PEPTIDES
CA2045578A1 (en) * 1989-01-31 1990-08-01 Megumi Kawai Anaphylatoxin-receptor ligands
US5137873A (en) * 1990-07-27 1992-08-11 The Children's Medical Center Corporation Substance p and tachykinin agonists for treatment of alzheimer's disease
US5753617A (en) * 1992-09-08 1998-05-19 Centocor, Inc. Peptide inhibitors of cellular adhesion
SE9403526D0 (en) * 1994-10-14 1994-10-14 Astra Ab New Peptides

Also Published As

Publication number Publication date
WO1998012214A1 (en) 1998-03-26
AU4405997A (en) 1998-04-14

Similar Documents

Publication Publication Date Title
DE69126568T2 (en) New physiologically active pig peptide (CNP-53)
DK1188768T3 (en) LHRH antagonist peptides
LV10720A (en) Peptides and pharmaceutical compositions on their bases
DK0966297T3 (en) Regulation of gastrointestinal motility
ES2229045T3 (en) DERIVATIVES OF THERAPEUTIC PEPTIDES.
TR199802534T2 (en) Leptin (OB Protein) fragmanlar�
KR910700062A (en) Deletion homologues of marganine peptides
SE9603468D0 (en) New compounds
ES2081817T3 (en) POLYPEPTIDE WITH MAIN SEQUENCES REPEATED THAT ARE FIXED IN THE CELL.
DE68917837T2 (en) Peptide compounds.
KR960702754A (en) VAGINAL PREPARATION CONTAINING PHYSIOLOGICALLY ACTIVE PEPTIDE containing physiologically active peptides
DK403789A (en) A NEW ANTIBIOTIC, MERSACIDIN, ITS PREPARATION AND USE AS A MEDICINE
ATE242202T1 (en) PEPTIDES
SE9501067D0 (en) New peptides
SE9603461D0 (en) New compounds
DK1154786T3 (en) Compositions for modulating mucus secretion
ATE42308T1 (en) PHARMACOLOGICALLY ACTIVE PEPTIDES.
FI971427A0 (en) Peptides and pharmaceutical compositions containing them
SE9603463D0 (en) New compounds
SE9603466D0 (en) New compounds
SE9603462D0 (en) New compounds
IT1241003B (en) PROCEDURE FOR THE PURIFICATION OF AN EQUIVALENT RECOMBINING POLYPEPTIDE HDIV, EQUIVALENT POLYPEPTIDE HDAG AND IMMUNOLOGICAL TESTS USING IT
YU2394A (en) LIZINE SO 6-CHLORO-5-FLUORO-3 - (- 2-TENOIL) -2-OXINDOL-1-CARBOXIDE
DE3682368D1 (en) MITOGENIC PEPTIDES.
ES2091571T3 (en) NEW ACTIVE PEPTIDIC DERIVATIVES IN THE CELL ADHESION PROCESSES, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.